AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 103 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $188,000 | -57.6% | 52,300 | +19.1% | 0.00% | -100.0% |
| Q4 2015 | $443,000 | -25.8% | 43,900 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $597,000 | +7.0% | 43,900 | +49.3% | 0.00% | +100.0% |
| Q2 2015 | $558,000 | -23.9% | 29,400 | +5.0% | 0.00% | -50.0% |
| Q1 2015 | $733,000 | +25.1% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $586,000 | -37.3% | 28,000 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $935,000 | +4.0% | 28,000 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $899,000 | -15.3% | 28,000 | +21.7% | 0.00% | -25.0% |
| Q1 2014 | $1,061,000 | -15.5% | 23,000 | +29.9% | 0.00% | -20.0% |
| Q4 2013 | $1,256,000 | -17.2% | 17,700 | 0.0% | 0.01% | -16.7% |
| Q3 2013 | $1,517,000 | +30.9% | 17,700 | -3.3% | 0.01% | +20.0% |
| Q2 2013 | $1,159,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |